Targeted sequencing of JRFendost003P2
"Targeted sequencing was performed using the MSK-IMPACT platform, targeting all exons of 341 'actionable' and cancer genes using custom oligonucleotides (Nimblegen SeqCap)."
alignment_software
bwa